Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome
- 1 August 1997
- journal article
- case report
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 25 (8), 1425-1430
- https://doi.org/10.1097/00003246-199708000-00034
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis BNew England Journal of Medicine, 1995
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995
- Mechanism of somatic mitochondrial DNA mutations associated with age and diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- Pathology of hepatitis C virus infectionHistopathology, 1995
- Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapyJournal of Internal Medicine, 1994
- Hepatomegaly with severe steatosis in HIV-seropositive patientsAIDS, 1993
- Lactic acidosis in critical illnessCritical Care Medicine, 1992
- Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)Annals of Internal Medicine, 1991
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS)Hepatology, 1987